Skip to main content
. Author manuscript; available in PMC: 2019 Jan 12.
Published in final edited form as: Clin Oncol (R Coll Radiol). 2013 May 27;25(8):451–460. doi: 10.1016/j.clon.2013.05.001

Fig 2.

Fig 2.

A 52-year-old man with a serum prostate-specific antigen (PSA) of 23 ng/dl with no previous biopsy. (A) Axial T2-weighted magnetic resonance imaging (MRI), (B) apparent diffusion coefficient map of diffusion-weighted MRI, (C) raw dynamic contrast-enhanced (DCE) MRI and (D) Ktrans map derived from DCE MRI show a lesion affecting almost the whole prostate gland (asterisk). The large lesion invades the rectum [(arrow in (A)] and seminal vesicles bilaterally [short arrows in (E)]. Additionally, a metastatic lymph node is present in the left obturator chain [dashed arrow in (E)]. Subsequent TRUS/MRI fusion-guided biopsy revealed a Gleason 5 + 5 tumour within the prostate.